Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients

Giuseppe Derosa, Pamela Maffioli, Sibilla A.T. Salvadeo, Ilaria Ferrari, Pietro D. Ragonesi, Fabrizio Querci, Ivano G. Franzetti, Gennaro Gadaleta, Leonardina Ciccarelli, Mario N. Piccinni, Angela D'Angelo, Arrigo F.G. Cicero
  • Metabolism, June 2010, Elsevier
  • DOI: 10.1016/j.metabol.2009.10.007

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1016/j.metabol.2009.10.007

The following have contributed to this page: Dr Arrigo FG CICERO